Aardvark Therapeutics

top of page

May 28

Aardvark Therapeutics CEO Tien Lee on this month's $85M series C and leveraging TAS2R to modulate hunger and as a weight loss strategy

Tien Lee describes how TAS2R is a bitter taste receptor that naturally activates gut hormones and gut-brain signaling and can be used to dam

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Klein Hersh is a precision executive search firm with over 25 years of proven success partnering with clients to deliver the visionary leaders shaping the future of life sciences and healthcare. We believe that the innovation behind a healthier world starts with bringing the best and brightest minds together. Our experienced team of dedicated experts is deeply immersed in every facet of pharma, biotech, and healthcare, and has developed trusted relationships with far-reaching talent networks.

Visit Klein Hersh